Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Oren

Showing results (121-130 of 172) with videos related to

Pageof 18
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2007
The Nedd4-binding partner 1 (N4BP1) protein is an inhibitor of the E3 ligase ItchAndrew Oberst, Martina Malatesta, Rami I Aqeilan, et al.
Cell Reports|February 9, 2016
RNF20 Links Histone H2B Ubiquitylation with Inflammation and Inflammation-Associated CancerOhad Tarcic, Ioannis S Pateras, Tomer Cooks, et al.
Cancer Research|March 17, 2007
Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cellsLilach Weisz, Alexander Damalas, Michalis Liontos, et al.
Life Science Alliance|May 4, 2026
A microRNA generated via lysosomal processing of ribosomal RNA suppresses proinflammatory responsesDan Michael, Ester Feldmesser, K Shanmugha Rajan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stressSladana Bursać, Maja Cokarić Brdovčak, Martin Pfannkuchen, et al.
Nature|July 31, 2020
The gut microbiome switches mutant p53 from tumour-suppressive to oncogenicEliran Kadosh, Irit Snir-Alkalay, Avanthika Venkatachalam, et al.
Genes & Development|March 26, 2016
The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulationYael Aylon, Anat Gershoni, Ron Rotkopf, et al.
Cancer Cell|March 16, 2010
Modulation of the vitamin D3 response by cancer-associated mutant p53Perry Stambolsky, Yuval Tabach, Giulia Fontemaggi, et al.
Life Science Alliance|November 21, 2018
LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic stateNoa Furth, Ioannis S Pateras, Ron Rotkopf, et al.
Molecular Oncology|September 16, 2023
TAZ facilitates breast tumor growth by promoting an immune-suppressive tumor microenvironmentAnat Gershoni, Ori Hassin, Nishanth Belugali Nataraj, et al.
Pageof 18

Showing results (121-130 of 172) with videos related to

Sort By:
Pageof 18
Proceedings of the National Academy of Sciences of the United States of America|June 27, 2007
The Nedd4-binding partner 1 (N4BP1) protein is an inhibitor of the E3 ligase ItchAndrew Oberst, Martina Malatesta, Rami I Aqeilan, et al.
Cell Reports|February 9, 2016
RNF20 Links Histone H2B Ubiquitylation with Inflammation and Inflammation-Associated CancerOhad Tarcic, Ioannis S Pateras, Tomer Cooks, et al.
Cancer Research|March 17, 2007
Mutant p53 enhances nuclear factor kappaB activation by tumor necrosis factor alpha in cancer cellsLilach Weisz, Alexander Damalas, Michalis Liontos, et al.
Life Science Alliance|May 4, 2026
A microRNA generated via lysosomal processing of ribosomal RNA suppresses proinflammatory responsesDan Michael, Ester Feldmesser, K Shanmugha Rajan, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2012
Mutual protection of ribosomal proteins L5 and L11 from degradation is essential for p53 activation upon ribosomal biogenesis stressSladana Bursać, Maja Cokarić Brdovčak, Martin Pfannkuchen, et al.
Nature|July 31, 2020
The gut microbiome switches mutant p53 from tumour-suppressive to oncogenicEliran Kadosh, Irit Snir-Alkalay, Avanthika Venkatachalam, et al.
Genes & Development|March 26, 2016
The LATS2 tumor suppressor inhibits SREBP and suppresses hepatic cholesterol accumulationYael Aylon, Anat Gershoni, Ron Rotkopf, et al.
Cancer Cell|March 16, 2010
Modulation of the vitamin D3 response by cancer-associated mutant p53Perry Stambolsky, Yuval Tabach, Giulia Fontemaggi, et al.
Life Science Alliance|November 21, 2018
LATS1 and LATS2 suppress breast cancer progression by maintaining cell identity and metabolic stateNoa Furth, Ioannis S Pateras, Ron Rotkopf, et al.
Molecular Oncology|September 16, 2023
TAZ facilitates breast tumor growth by promoting an immune-suppressive tumor microenvironmentAnat Gershoni, Ori Hassin, Nishanth Belugali Nataraj, et al.
Pageof 18